Drugs / Lamivudine-Zidovudine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01061151 | Mar 2011 → Sep 2016 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lamivudine-Zidovudine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01061151 ↗ |
| Known as | 3TC-ZDV | “Lamivudine-Zidovudine (3TC-ZDV)” NCT01061151 ↗ |